
To our readers,
Chips, pastes, putties, gels, powders, wedges, DBM, BMP, and assorted kits—the list of bone allografts and substitutes is long and confusing. These biologic materials have a big impact on the OR budget, but they are more than just another line of surgical supplies.
Biologics originate with a family’s decision to donate a loved one’s tissue. From there, they may pass through many hands until they are brought to the operating room in a form that promises to help a patient heal a defect caused by injury or disease.
In making decisions about which biologics to acquire, OR teams have to consider a variety of issues:
In this supplement, OR Manager is publishing information to help in managing this complex area. We believe we have found the right partner in the Musculoskeletal Transplant Foundation (MTF).
The supplement is a collection of articles that appeared in OR Manager from October 2010 through February 2011. The articles are intended to help you and your team better understand and manage bone biologics.
The articles begin with an overview of the tissue donation process and donor screening. Other articles feature:
We hope these articles assist you and your team in making good decisions about the use of bone allografts, a gift of life.
—Pat Patterson
Editor, OR Manager—Kim Rounds
Vice President, Marketing
Musculoskeletal Transplant Foundation